Technical Analysis for CMPX - Compass Therapeutics Inc

Grade Last Price % Change Price Change
A 2.43 -1.62% -0.0400
CMPX closed up 0.82 percent on Wednesday, May 18, 2022, on 29 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup -1.62%
180 Bullish Setup Bullish Swing Setup -1.62%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.62%
Upper Bollinger Band Walk Strength -1.62%
Wide Bands Range Expansion -1.62%
Gapped Down Weakness -1.62%
Upper Bollinger Band Walk Strength -0.82%
Wide Bands Range Expansion -0.82%
Gapped Up Strength -0.82%
Upper Bollinger Band Touch Strength -0.82%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Bullish 180 Entry about 7 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 7 hours ago
1,2,3, Pullback Entry about 7 hours ago
Rose Above Previous Day's High about 7 hours ago
Down 3% about 7 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Compass Therapeutics, Inc., a clinical-stage biotechnology company, develops and discovers antibody therapeutics for treating solid tumors and hematological malignancies in the United States. The company's lead product candidate is CTX-471, a monoclonal antibody agonist of CD137, a co-stimulatory receptor on immune cells that is in Phase 1b clinical trial, as well as in preclinical stage in combination with trastuzumab and/or cetuximab for the treatment of oncology. Its products in preclinical development stage include CTX-8371, a bispecific antibody that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Other
Industry: Other
Keywords: Medicine Biotechnology Medical Specialties Clinical Medicine Immunology Immune System Antibodies Solid Tumors Cancer Immunotherapy Monoclonal Antibody Monoclonal Antibody Therapy Trastuzumab Hematological Malignancies Immune Checkpoint Programmed Cell Death Protein 1

Is CMPX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.0
52 Week Low 1.25
Average Volume 222,281
200-Day Moving Average 2.8296
50-Day Moving Average 1.5984
20-Day Moving Average 1.7785
10-Day Moving Average 2.0740
Average True Range 0.2881
RSI 71.35
ADX 33.45
+DI 33.9632
-DI 11.0582
Chandelier Exit (Long, 3 ATRs) 2.1357
Chandelier Exit (Short, 3 ATRs) 2.1643
Upper Bollinger Bands 2.6258
Lower Bollinger Band 0.9312
Percent B (%b) 0.91
BandWidth 95.2825
MACD Line 0.2401
MACD Signal Line 0.1270
MACD Histogram 0.1131
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.7399
Resistance 3 (R3) 2.7198 2.6099 2.6949
Resistance 2 (R2) 2.6099 2.5411 2.6199 2.6799
Resistance 1 (R1) 2.5399 2.4987 2.5749 2.5600 2.6649
Pivot Point 2.4300 2.4300 2.4475 2.4400 2.4300
Support 1 (S1) 2.3600 2.3612 2.3950 2.3801 2.2751
Support 2 (S2) 2.2501 2.3188 2.2601 2.2601
Support 3 (S3) 2.1801 2.2501 2.2451
Support 4 (S4) 2.2002